Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia D Wulfkuhle

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Expert Review of Proteomics|October 11, 2018
Phosphoprotein-based drug target activation mapping for precision oncology: a view to the futureMariaelena Pierobon, Emanuel F Petricoin, Julia D Wulfkuhle
Nature Reviews. Cancer|April 3, 2003
Proteomic applications for the early detection of cancerJulia D Wulfkuhle, Lance A Liotta, Emanuel F Petricoin
Current Opinion in Molecular Therapeutics|June 28, 2005
Reverse-phase protein microarrays for tissue-based analysisRuna Speer, Julia D Wulfkuhle, Lance A Liotta, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 15, 2017
Innovations in Clinical Trial Design in the Era of Molecular ProfilingJulia D Wulfkuhle, Alexander Spira, Kirsten H Edmiston, et al.
JAMA|April 8, 2004
STUDENTJAMA. Molecular technologies for personalized cancer managementRani K Hasan, Julia D Wulfkuhle, Lance A Liotta, et al.
Nature Clinical Practice. Oncology|May 10, 2006
Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarraysJulia D Wulfkuhle, Kirsten H Edmiston, Lance A Liotta, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2008
Reverse phase protein microarrays for monitoring biological responsesVirginia Espina, Julia D Wulfkuhle, Valerie S Calvert, et al.
Advances in Experimental Medicine and Biology|August 12, 2003
Proteomic approaches to the diagnosis, treatment, and monitoring of cancerJulia D Wulfkuhle, Cloud P Paweletz, Patricia S Steeg, et al.
International Journal of Cancer|February 14, 2012
Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell linesTon van Agthoven, Marcia F E Godinho, Julia D Wulfkuhle, et al.
Molecular Cancer Therapeutics|June 30, 2011
Compensatory pathways induced by MEK inhibition are effective drug targets for combination therapy against castration-resistant prostate cancerDaniel Gioeli, Winfried Wunderlich, Judith Sebolt-Leopold, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Expert Review of Proteomics|October 11, 2018
Phosphoprotein-based drug target activation mapping for precision oncology: a view to the futureMariaelena Pierobon, Emanuel F Petricoin, Julia D Wulfkuhle
Nature Reviews. Cancer|April 3, 2003
Proteomic applications for the early detection of cancerJulia D Wulfkuhle, Lance A Liotta, Emanuel F Petricoin
Current Opinion in Molecular Therapeutics|June 28, 2005
Reverse-phase protein microarrays for tissue-based analysisRuna Speer, Julia D Wulfkuhle, Lance A Liotta, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 15, 2017
Innovations in Clinical Trial Design in the Era of Molecular ProfilingJulia D Wulfkuhle, Alexander Spira, Kirsten H Edmiston, et al.
JAMA|April 8, 2004
STUDENTJAMA. Molecular technologies for personalized cancer managementRani K Hasan, Julia D Wulfkuhle, Lance A Liotta, et al.
Nature Clinical Practice. Oncology|May 10, 2006
Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarraysJulia D Wulfkuhle, Kirsten H Edmiston, Lance A Liotta, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2008
Reverse phase protein microarrays for monitoring biological responsesVirginia Espina, Julia D Wulfkuhle, Valerie S Calvert, et al.
Advances in Experimental Medicine and Biology|August 12, 2003
Proteomic approaches to the diagnosis, treatment, and monitoring of cancerJulia D Wulfkuhle, Cloud P Paweletz, Patricia S Steeg, et al.
International Journal of Cancer|February 14, 2012
Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell linesTon van Agthoven, Marcia F E Godinho, Julia D Wulfkuhle, et al.
Molecular Cancer Therapeutics|June 30, 2011
Compensatory pathways induced by MEK inhibition are effective drug targets for combination therapy against castration-resistant prostate cancerDaniel Gioeli, Winfried Wunderlich, Judith Sebolt-Leopold, et al.
Pageof 5